About Osrodek Badan Klinicznych CLINSANTE S.C.
Clinical Trials at Osrodek Badan Klinicznych CLINSANTE S.C.
During the past decade, Osrodek Badan Klinicznych CLINSANTE S.C. conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on
average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Osrodek Badan Klinicznych CLINSANTE S.C." #1 sponsor was "Janssen Pharmaceutica N.V., Belgium" with 1 trials, followed by "Janssen Research & Development, LLC" with 1 trials
sponsored, "Janssen-Cilag International NV" with 1 trials sponsored, "Janssen-Cilag Ltd." with 1 trials sponsored and "Milestone Pharmaceuticals Inc."
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Osrodek Badan Klinicznych CLINSANTE S.C."
#1 collaborator was "IQVIA Biotech" with 1 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Osrodek Badan Klinicznych CLINSANTE S.C.
According to Clinical.Site data, the most researched conditions in "Osrodek Badan Klinicznych CLINSANTE S.C." are
"Depressive Disorder, Major" (3 trials), "Bipolar Disorder" (1 trials) and "Paroxysmal Supraventricular Tachycardia" (1 trials). Many other conditions were trialed in "Osrodek Badan Klinicznych CLINSANTE S.C." in a lesser frequency.
Clinical Trials Intervention Types at Osrodek Badan Klinicznych CLINSANTE S.C.
Most popular intervention types in "Osrodek Badan Klinicznych CLINSANTE S.C." are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "SSRI/SNRI" (2 trials), "Esketamine" (1 trials), "Esketamine 28 mg" (1 trials) and "Esketamine 56 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Osrodek Badan Klinicznych CLINSANTE S.C.
The vast majority of trials in "Osrodek Badan Klinicznych CLINSANTE S.C." are
5 trials for "All" genders.
Clinical Trials Status at Osrodek Badan Klinicznych CLINSANTE S.C.
Currently, there are NaN active trials in "Osrodek Badan Klinicznych CLINSANTE S.C.".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Osrodek Badan Klinicznych CLINSANTE S.C.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Osrodek Badan Klinicznych CLINSANTE S.C., 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".